SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: Florence Griffith Joyner (HR-ML033)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 11judgment calls in the dossier
- 1protocol deviations
- 2orders and referrals without results in the record
- 1evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check the ILAE 2014 diagnosis after one seizure with a cavernous malformation (and earlier seizures by history), levetiracetam rather than lamotrigine, early lesionectomy after one evaluated seizure, the California reporting duty, the SUDEP counseling and its one-visit delay, and the return-to-training schedule. |
| provenance review | not_started | | | Recent-death rule: only what was reported during her life (the Associated Press report of the 1996 seizure) and the coroner's findings as reported by news organizations and World Athletics, plus Olympedia and Encyclopedia.com for her life and career. The earlier treated seizures come from coroner's records reported by Salon and are graded probable. |
| safe messaging review | not_started | | | No mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Her death is recorded once, without detail. No relative is named or given a role in the modern episode, and no statement, decision or health fact is attributed to any relative. Rumors about performance-enhancing drugs are not part of the clinical record. |
Judgment calls (dossier editorial resolutions)
- Recent-death rule. Griffith Joyner died in 1998, so the rule applies. The case uses what was reported during her life (the Associated Press report of the 1996 seizure), the coroner’s findings as reported by news organizations and World Athletics, and reference works for her life and career. The earlier treated seizures come from the coroner’s investigation records as reported by Salon after her death; they are graded probable (CLM-0006) and are used only as history. On November 5, 2026 the project lead accepted this source under the recent-death rule because it is documented and annotated here. No sick visit is added. Her death is recorded once (CLM-0007), in plain words. No claim concerns mental health or substance use; the modern mood screens are synthetic and below the threshold for a safety assessment.
- What is left out. The family asked in 1996 that no details of that seizure be released, and the modern episode respects that: it adds no account of the real seizure beyond what was published, and the description of the seizure in the modern notes (witnessed stiffening and jerking, confusion afterwards, no memory of it) is synthetic and generic. Details from the coroner’s scene and investigation notes and the statements of relatives are not used. Rumors about performance-enhancing drugs, which were never proven, are not part of the clinical record; the coroner’s toxicology showed only over-the-counter medicines in usual amounts, and an Associated Press report said the autopsy found no indication of drug use (CBS News).
- Real people. No relative is named, and no statement, decision or health fact is attributed to any relative. The household is described only as married with a young child, without names or roles; the nocturnal detection watch alerts “a contact she chose.” Officials quoted in the reports appear only as their sources. The family history is left empty.
- Conflicts. (1) Her given names appear as Delorez Florence (Olympedia) and Florence Delorez (Encyclopedia.com); CLM-0001 records both. (2) The coroner’s investigator was reported as saying cavernous angiomas are found in about 25 percent of the population (CBS News) and in 0.25 percent (World Athletics); the second matches the medical literature, and neither figure is used. (3) The Irish Times spells the chief forensic pathologist’s name differently from the other reports; the name is not used. (4) Her stay after the 1996 seizure is described as release the next day (Associated Press, 1996) and as a day under observation (Encyclopedia.com), which agree. (5) The Los Angeles Times and New York Times reports could not be fetched and are not cited; the Los Angeles Times is quoted only through Salon, and that quotation is not used.
- Alias. “Flo-Jo” appears in no other record and is used as an alias, with her full name. “Griffith” is part of her family name, not an alias; `identity.name_parts` gives the family name as “Griffith Joyner.”
- Index age and dates. The index visit on April 22, 2026 maps to April 22, 1996, when she was 36: about two and a half weeks after the seizure on a flight, the first seizure reported publicly in her life. The synthetic date of birth is December 21, 1989 (shift 30 years). The chronic-care visits on May 5, May 27, July 21 and October 20, 2026, the surgery on June 16, and the preventive visit on August 25, 2026 (age 36, so a periodic adult preventive visit) map to the same days of 1996, two years before her death. Past medical history includes the treated seizures of 1990 to 1994 and the April 1996 seizure, both before the index date.
- Synthetic clinical picture. The presenting problem is the seizure on the flight (R56.9), resolved at the consultation when the EEG and MRI give the diagnosis: focal epilepsy with structural cause from a left orbitofrontal cavernous malformation, the site the coroner reported. Because the record documents earlier treated seizures, the modern episode does not call this her first seizure; it is evaluated as a new seizure under the AAN/AES first seizure guideline because no earlier records are available, and the diagnosis of epilepsy rests on the ILAE 2014 single-seizure criterion with an epileptogenic lesion, supported by the history. The seizure type, EEG findings, MRI details (size, hemosiderin rim, developmental venous anomaly, single lesion), levetiracetam, folic acid, the lesionectomy and its pathology, and every value are synthetic. Levetiracetam was chosen over lamotrigine for an immediate effective dose without contraceptive interaction; valproate is named only as the drug to avoid. Early lesionectomy after one evaluated seizure is a judgment call supported by the Angioma Alliance guideline for an accessible epileptogenic lesion. California’s mandatory physician report is applied because she lived in California. Height 170 cm matches her published athletic height; weights are synthetic. Qualitative results (pregnancy test, EEG, MRI, pathology, cervical screening, HIV and hepatitis tests) appear only in procedure and note text.
- Sleep and SUDEP. The SUDEP counseling follows the AAN/AES guideline in general terms (tonic-clonic seizures as the main risk, adherence, regular sleep, nocturnal supervision or detection). It deliberately does not discuss sleeping position or bedding, so that no part of the modern episode reads as commentary on the circumstances of her death.
- Preventive visit. A periodic adult preventive visit at 36 (CPT 99395 with 99497 in plain text), ten weeks after surgery. Judgment calls: cervical cytology with HPV co-testing; once-in-adulthood HIV, hepatitis C and hepatitis B screening; intimate partner violence screening for a woman of reproductive age; folic acid continued; mammography from 40; no diabetes or lipid screening at 36 with a normal BMI and no risk factor; Tdap given. Advance care planning records only her general preferences and an unnamed agent.
- Focused visits. The four chronic-care follow-ups (two weeks with the diagnosis and consultation, three weeks on levetiracetam, five weeks after surgery, six and a half months after the seizure) are documented as focused visits on the AAN/AES first seizure guideline, the ILAE 2014 definition, the Angioma Alliance guideline, the AAN/AES SUDEP guideline, the AAN/AES/SMFM 2024 teratogenesis guideline and the ILAE/IFCN detection guideline. One deviation is recorded instead of an invented event: the SUDEP discussion the guideline calls for at diagnosis was not held at the consultation visit, because the visit was taken up by the diagnosis, the medication and the surgical question; it was held three weeks later, no seizure occurred in the interval, and SUDEP was added to the clinic’s new-diagnosis checklist. Synthetic findings introduced: mild irritability and tiredness on levetiracetam that settled without a change of drug, and complete resection on the postoperative MRI.
- Consultation. The epilepsy referral, written at intake before the EEG and MRI, and the consultation by Rahul Mehta-Sorensen, MD (a fictional consultant), on the day of the two-week visit, are S. The consultant answers the five referral questions in line with what the record shows afterwards: focal epilepsy with structural cause under ILAE 2014; levetiracetam with folic acid, contraception and pregnancy planning, and valproate avoided; neurosurgical evaluation, which led to complete lesionectomy; SUDEP counseling at the next visit, with a detection watch; and safety, flying, graded training and driving through the California DMV.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-05-05 Progress note 02 (C-CDA) | SUDEP counseling | At diagnosis of epilepsy | Not discussed today: the visit was taken up by the diagnosis, the medication and the surgical question. A deviation from the AAN/AES guideline, which calls for the discussion at diagnosis. Corrective action: booked as the first item at the next visit in three weeks |
Orders and referrals without results in the record
| Visit | Type | Item | Status | Detail |
|---|
2026-05-05 Progress note 02 (C-CDA) | Referral | Neurosurgical evaluation of an epileptogenic cavernous malformation | Ordered | Requested today, within three weeks |
2026-05-05 Progress note 02 (C-CDA) | Self-management | Nocturnal seizure detection | Ordered | Wrist-worn detection watch ordered |
Evidence to check
Retrospective claims (R)
None.
Sensitive claims
| Claim | Grade | Statement |
|---|
| CLM-0007 | D | She died in her sleep at her home in Mission Viejo, California, on September 21, 1998, at 38. The Orange County Sheriff-Coroner reported that she died of positional asphyxia during an epileptic seizure, and that the seizure was caused by a congenital cavernous angioma (cavernous malformation) of the left orbital frontal cerebrum. |
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
None.